user avatar
CellCentric
@CellCentric
Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.
Cambridge, UK
cellcentric.com
Joined November 2009
375
Following
697
Followers
Posts
@cellcentric hasn’t posted
When they do, their posts will show up here.